Dean Gregory
Net worth: 263 644 $ as of 2026-05-30
Net worth: 263 644 $ as of 2026-05-30
Dean A. Gregory is currently Director at Illinois Biotechnology Industry Organization and Independent Director at Cerus Corp.
since 2024.
Formerly, Mr. Gregory was President-Medical Devices at Fresenius Kabi Pharmaceuticals Holding, Inc. (United States) from 2012 to 2024, Senior Vice President-Sales & Operations at Fenwal, Inc. from 2010 to 2012, and VP-Business Development, Strategy & Marketing ROW at Baxter International, Inc. from 2002 to 2007.
Education includes an MBA from DePaul University and an undergraduate degree from the University of Illinois.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CERUS CORPORATION 0.04% | 2026-06-01 | 86,725 ( 0.04% ) | 263 644 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| CERUS CORPORATION | Director/Board Member | 2024-06-30 |
Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Life science industry association | Director/Board Member | 2010-01-19 |
| Companies | Position | End |
|---|---|---|
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States)
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 2024-02-29 |
Fenwal, Inc.
Fenwal, Inc. BiotechnologyHealth Technology Manufactures blood collection and transfusion systems | Chief Operating Officer | 2010-03-17 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 2007-01-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 7 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Cerus Corp.
Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
DePaul University
DePaul University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fenwal, Inc.
Fenwal, Inc. BiotechnologyHealth Technology Manufactures blood collection and transfusion systems | Health Technology |
Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Life science industry association | Commercial Services |
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States)
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions